Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lactate dehydrogenase A chain (LDHA) is a critical enzyme that functions as a monomer within the lactate dehydrogenase (LDH) enzyme complex. It catalyzes the reversible conversion of pyruvate to L-lactate, supporting glycolysis and ATP production, especially under low oxygen conditions. LDHA is predominantly expressed in muscle tissues, tumors, blood cells and heart muscle and its activity is regulated by substrate availability, pH levels, post-translational modifications, and NADH levels. Elevated LDHA levels are observed in many human cancers, making it a potential therapeutic target.
LDHA inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lactate Dehydrogenase A Chain (LDHA).